EA201201666A1 - Промежуточные соединения агомелатина и способ их получения - Google Patents
Промежуточные соединения агомелатина и способ их полученияInfo
- Publication number
- EA201201666A1 EA201201666A1 EA201201666A EA201201666A EA201201666A1 EA 201201666 A1 EA201201666 A1 EA 201201666A1 EA 201201666 A EA201201666 A EA 201201666A EA 201201666 A EA201201666 A EA 201201666A EA 201201666 A1 EA201201666 A1 EA 201201666A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- agomelatine
- preparation
- intermediate compounds
- present
- new intermediates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Abstract
Настоящее изобретение относится к промежуточным соединениям для получения агомелатина, так же, как и к способам их получения. Промежуточное соединение настоящего изобретения для получения агомелатина представляет собой соединение А в соответствии с следующей формулой. Также обеспечены два новых промежуточных соединения. Когда применяются эти новые промежуточные соединения для получения агомелатина, способ является простым для управления, хорошо контролируемым, и дает продукт с высокой чистотой, без сложных операций, таких как ректификация и разделение хроматографией на колонке, и является подходящим для промышленного производства. При этом, способы получения самих двух новых промежуточных соединений являются простыми и с высоким выходом, только когда применяют наиболее широко используемый 7-метокситетралон в качестве исходного стартового материала и проводят одну стадию реакции для получения промежуточных соединений с последующей еще одной стадией преобразования промежуточного соединения в желаемый продукт агомелатин. Упомянутые процессы реакции очень упрощены, с улучшенным выходом реакции, а также преодолевают трудности в очистке предыдущего способа при сравнении с предыдущей методикой получения агомелатина. Обычно выход настоящего изобретения составляет свыше 70%.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101973700A CN102276492B (zh) | 2010-06-08 | 2010-06-08 | 阿戈美拉汀中间体及其制备方法 |
PCT/CN2011/075438 WO2011153939A1 (en) | 2010-06-08 | 2011-06-08 | Agomelatine intermediates and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201201666A1 true EA201201666A1 (ru) | 2013-05-30 |
EA020271B1 EA020271B1 (ru) | 2014-09-30 |
Family
ID=45097542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201201666A EA020271B1 (ru) | 2010-06-08 | 2011-06-08 | Промежуточные соединения агомелатина и способ их получения |
Country Status (40)
Country | Link |
---|---|
US (1) | US8779199B2 (ru) |
EP (1) | EP2580189B1 (ru) |
JP (1) | JP5519863B2 (ru) |
KR (1) | KR101470874B1 (ru) |
CN (1) | CN102276492B (ru) |
AP (1) | AP3205A (ru) |
AU (1) | AU2011264206B2 (ru) |
BR (1) | BR112012031086B1 (ru) |
CA (1) | CA2801822C (ru) |
CL (1) | CL2012003371A1 (ru) |
CR (1) | CR20120592A (ru) |
CU (1) | CU24148B1 (ru) |
CY (1) | CY1119857T1 (ru) |
DK (1) | DK2580189T3 (ru) |
EA (1) | EA020271B1 (ru) |
EC (1) | ECSP12012328A (ru) |
ES (1) | ES2656968T3 (ru) |
GE (1) | GEP20156234B (ru) |
GT (1) | GT201200328A (ru) |
HR (1) | HRP20171751T1 (ru) |
HU (1) | HUE035850T2 (ru) |
IL (1) | IL223180A (ru) |
LT (1) | LT2580189T (ru) |
MA (1) | MA34292B1 (ru) |
ME (1) | ME02992B (ru) |
MX (1) | MX2012013870A (ru) |
MY (1) | MY160954A (ru) |
NI (1) | NI201200177A (ru) |
NO (1) | NO2580189T3 (ru) |
NZ (1) | NZ604081A (ru) |
PE (1) | PE20130252A1 (ru) |
PL (1) | PL2580189T3 (ru) |
PT (1) | PT2580189T (ru) |
RS (1) | RS56659B1 (ru) |
SG (1) | SG185667A1 (ru) |
SI (1) | SI2580189T1 (ru) |
TN (1) | TN2012000542A1 (ru) |
UA (1) | UA104684C2 (ru) |
WO (1) | WO2011153939A1 (ru) |
ZA (1) | ZA201208764B (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012046253A2 (en) * | 2010-10-08 | 2012-04-12 | Msn Laboratories Limited | Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms |
CN102452951B (zh) * | 2010-10-25 | 2014-02-19 | 天津泰普药品科技发展有限公司 | 阿戈美拉汀及其药物组合物 |
ITMI20121444A1 (it) | 2012-08-27 | 2014-02-28 | Procos Spa | Processo per la produzione di agomelatine |
EP2921473B1 (en) * | 2012-10-09 | 2017-09-27 | Jiangxi Synergy Pharmaceutical Co. Ltd. | 1-cyan-1-(7-methoxyl-1-naphtyl) methanol ester compound and preparation method and use thereof |
CN112574066A (zh) * | 2019-09-27 | 2021-03-30 | 江苏豪森药业集团有限公司 | 一种阿戈美拉汀中间体的制备方法 |
JP2023506144A (ja) * | 2019-12-23 | 2023-02-15 | ディーエスエム アイピー アセッツ ビー.ブイ. | 脱水素化方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
DE10229842A1 (de) | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
FR2866334B1 (fr) * | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine |
FR2866335B1 (fr) | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
FR2866336B1 (fr) * | 2004-02-13 | 2006-03-24 | Servier Lab | Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl) acetonitrile et application a la synthese de l'agomelatine |
CN101472884A (zh) * | 2006-06-20 | 2009-07-01 | 弗·哈夫曼-拉罗切有限公司 | 1,2,3,4-四氢化萘和茚满衍生物及其用途 |
CN101486665B (zh) * | 2009-03-03 | 2013-04-17 | 上海医药工业研究院 | 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法 |
EP2705023A4 (en) * | 2011-01-04 | 2014-11-19 | Symed Labs Ltd | PROCESSES FOR THE PREPARATION OF N- [2- (7-METHOXY-1-NAPHTHYLLELYHYL) ACETAMIDE |
-
2010
- 2010-06-08 CN CN2010101973700A patent/CN102276492B/zh active Active
-
2011
- 2011-06-08 US US13/702,388 patent/US8779199B2/en active Active
- 2011-06-08 AP AP2013006659A patent/AP3205A/xx active
- 2011-06-08 PL PL11791930T patent/PL2580189T3/pl unknown
- 2011-06-08 NO NO11791930A patent/NO2580189T3/no unknown
- 2011-06-08 ME MEP-2018-6A patent/ME02992B/me unknown
- 2011-06-08 EA EA201201666A patent/EA020271B1/ru unknown
- 2011-06-08 LT LTEP11791930.8T patent/LT2580189T/lt unknown
- 2011-06-08 KR KR1020137000375A patent/KR101470874B1/ko active IP Right Grant
- 2011-06-08 UA UAA201300117A patent/UA104684C2/ru unknown
- 2011-06-08 CA CA2801822A patent/CA2801822C/en not_active Expired - Fee Related
- 2011-06-08 SG SG2012085296A patent/SG185667A1/en unknown
- 2011-06-08 PE PE2012002205A patent/PE20130252A1/es active IP Right Grant
- 2011-06-08 RS RS20171239A patent/RS56659B1/sr unknown
- 2011-06-08 AU AU2011264206A patent/AU2011264206B2/en not_active Ceased
- 2011-06-08 MA MA35423A patent/MA34292B1/fr unknown
- 2011-06-08 DK DK11791930.8T patent/DK2580189T3/da active
- 2011-06-08 SI SI201131371T patent/SI2580189T1/en unknown
- 2011-06-08 CU CU20120163A patent/CU24148B1/es active IP Right Grant
- 2011-06-08 PT PT117919308T patent/PT2580189T/pt unknown
- 2011-06-08 MY MYPI2012700965A patent/MY160954A/en unknown
- 2011-06-08 JP JP2013513535A patent/JP5519863B2/ja not_active Expired - Fee Related
- 2011-06-08 GE GEAP201112941A patent/GEP20156234B/en unknown
- 2011-06-08 BR BR112012031086-0A patent/BR112012031086B1/pt not_active IP Right Cessation
- 2011-06-08 WO PCT/CN2011/075438 patent/WO2011153939A1/en active Application Filing
- 2011-06-08 NZ NZ604081A patent/NZ604081A/en not_active IP Right Cessation
- 2011-06-08 EP EP11791930.8A patent/EP2580189B1/en active Active
- 2011-06-08 MX MX2012013870A patent/MX2012013870A/es active IP Right Grant
- 2011-06-08 HU HUE11791930A patent/HUE035850T2/en unknown
- 2011-06-08 ES ES11791930.8T patent/ES2656968T3/es active Active
-
2012
- 2012-11-21 ZA ZA2012/08764A patent/ZA201208764B/en unknown
- 2012-11-21 TN TNP2012000542A patent/TN2012000542A1/en unknown
- 2012-11-22 CR CR20120592A patent/CR20120592A/es unknown
- 2012-11-22 IL IL223180A patent/IL223180A/en active IP Right Grant
- 2012-11-30 CL CL2012003371A patent/CL2012003371A1/es unknown
- 2012-11-30 NI NI201200177A patent/NI201200177A/es unknown
- 2012-12-07 EC ECSP12012328 patent/ECSP12012328A/es unknown
- 2012-12-07 GT GT201200328A patent/GT201200328A/es unknown
-
2017
- 2017-11-14 HR HRP20171751TT patent/HRP20171751T1/hr unknown
-
2018
- 2018-01-22 CY CY20181100076T patent/CY1119857T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201201666A1 (ru) | Промежуточные соединения агомелатина и способ их получения | |
PH12015501258A1 (en) | Methods of synthesizing a prostacyclin analog | |
WO2014043706A8 (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
MX2013011257A (es) | Proceso para la preparacion de dronedarona por n-butilacion. | |
DK2019114T3 (da) | Fremgangsmåde til fremstilling af Drospirenon | |
MX2020010773A (es) | Metodo para la preparacion del compuesto de pirroloaminopiridazino na y sus intermedios. | |
MX2015010934A (es) | Metodo para producir un compuesto triciclico, y un compuesto triciclico capaz de producirse por dicho metodo de produccion. | |
EA201990237A1 (ru) | Новые способы получения стимуляторов растворимой гуанилатциклазы | |
EA200801348A1 (ru) | Способ получения промежуточных соединений хлорамфеникола или его аналогов | |
MX2018010128A (es) | Toxina nueva y metodo de preparacion de un intermediario de la misma. | |
MX2023000059A (es) | Metodo de preparacion de compuesto de fenilisoxazolina. | |
MY147894A (en) | Process for preparing intermediate compound for synthesizing an antiulcerant | |
RU2550510C1 (ru) | Способ получения этил(4е)-5-хлорпент-4-еноата | |
EA202090650A1 (ru) | Способ прямого получения этанола из синтез-газа | |
JP5918624B2 (ja) | 光学活性含フッ素5,6−ジヒドロピリドン誘導体及びその製造方法 | |
CN105541797A (zh) | 盐酸巴尼地平的合成工艺 | |
CO6592020A2 (es) | Intemedios de agomelatina y método de preparación de éstos | |
PH12021550022A1 (en) | Spirobiindane derivatives and a process for preparation thereof | |
RU2515240C1 (ru) | Способ получения 1-[(2е,4е)-дека-2,4-диеноил]пирролидина | |
CN103880705B (zh) | 二肟基紫罗兰酮及其制备方法和应用 | |
MD3889B1 (en) | Process for obtaining 11-bishomodrim-8(9)-en-12-one | |
RU2500664C1 (ru) | Способ получения (2е,4е)-n-изобутилдека-2,4-диенамида | |
JP5964727B2 (ja) | α―フムラジエノンの製造方法 | |
TH133952A (th) | สารมัธยันตร์อะโกเมลาทีน (Agomelatine intermediate) และ วิธีการเตรียมของสารนั้น | |
CN106117206A (zh) | 医药中间体4-三氟甲基鸟嘌呤的合成方法 |